{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:52:48Z","timestamp":1781635968691,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Herzzentrum G\u00f6ttingen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Recent evidence suggests glial dysfunction, particularly involving oligodendrocytes and myelin, as an important part of the primary disease mechanism of sporadic Creutzfeldt\u2013Jakob disease. To the best of our knowledge, cerebrospinal fluid (CSF) biomarkers reflecting oligodendrocyte or myelin damage have not yet been systematically investigated in this context. CSF samples from patients with sporadic Creutzfeldt\u2013Jakob disease (CJD), Alzheimer's disease (AD) and non-neurodegenerative controls (n\u2009=\u200918, respectively) were included in the study, and levels of myelin basic protein (MBP), neural\/glial antigen 2 (NG2) and cyclic nucleotide 3\u2032-phosphodiesterase (CNPase) were quantified. Additionally, p25-positive cells were quantified in autopsy tissue from the frontal and parietal cortical regions of five patients with CJD and four controls. In the primary cohort, MBP quantification revealed significantly higher CSF levels in CJD compared to AD (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.004) and controls (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0001) and this difference remained significant after adjustment for age and neurofilament light chain (NfL), indicating that MBP elevations cannot be explained solely by neuroaxonal degeneration. Significant differences were also found for CNPase in CJD compared to AD (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0011) and controls (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0004). There were no differences in NG2 levels (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&gt;\u20090.05) among the groups. However, no significant differences were observed in the total number of p25-positive mature oligodendrocytes between CJD and controls in cortical brain tissue (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&gt;\u20090.05). Additionally, MBP and NfL were quantified in a second cohort of 28 CJD and 20 biomarker-defined AD patients. In this cohort, characterized by more advanced AD pathology, MBP strongly covaried with NfL and no longer differed between diagnostic groups, suggesting a greater influence of neuroaxonal injury on MBP levels in advanced disease stages. In conclusion, in CJD, MBP elevations appear to be only partly related to neuroaxonal degeneration and may reflect disease-related myelin involvement.\n                  <\/jats:p>","DOI":"10.1186\/s40478-026-02247-5","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T08:45:28Z","timestamp":1770713128000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Alterations in cerebrospinal fluid levels of myelin- and oligodendrocyte-related proteins in sporadic Creutzfeldt\u2013Jakob disease"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4077-2852","authenticated-orcid":false,"given":"Fabian","family":"Maass","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lille","family":"Kurvits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"B\u00e4hr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Stadelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Zechel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sezgi","family":"Canaslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Zerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"2247_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41572-024-00497-y","volume":"10","author":"I Zerr","year":"2024","unstructured":"Zerr I, Ladogana A, Mead S, Hermann P, Forloni G, Appleby BS (2024) Creutzfeldt\u2013Jakob disease and other prion diseases. Nat Rev Dis Prime 10:14","journal-title":"Nat Rev Dis Prime"},{"key":"2247_CR2","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1093\/brain\/awu298","volume":"137","author":"E Caverzasi","year":"2014","unstructured":"Caverzasi E, Mandelli ML, DeArmond SJ, Hess CP, Vitali P, Papinutto N et al (2014) White matter involvement in sporadic Creutzfeldt\u2013Jakob disease. Brain 137:3339\u20133354","journal-title":"Brain"},{"key":"2247_CR3","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1093\/brain\/awaf032","volume":"148","author":"F K\u00fc\u00e7\u00fckali","year":"2025","unstructured":"K\u00fc\u00e7\u00fckali F, Hill E, Watzeels T, Hummerich H, Campbell T, Darwent L et al (2025) Multiomic analyses direct hypotheses for Creutzfeldt-Jakob disease risk genes. Brain 148:3350\u20133363","journal-title":"Brain"},{"key":"2247_CR4","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1007\/s12035-017-0560-0","volume":"55","author":"B Jang","year":"2018","unstructured":"Jang B, Jeon Y-C, Shin H-Y, Lee Y-J, Kim H, Kondo Y et al (2018) Myelin basic protein citrullination, a hallmark of central nervous system demyelination, assessed by novel monoclonal antibodies in prion diseases. Mol Neurobiol 55:3172\u20133184","journal-title":"Mol Neurobiol"},{"key":"2247_CR5","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1080\/19336896.2018.1500076","volume":"12","author":"P Andres Benito","year":"2018","unstructured":"Andres Benito P, Dominguez Gonzalez M, Ferrer I (2018) Altered gene transcription linked to astrocytes and oligodendrocytes in frontal cortex in Creutzfeldt\u2013Jakob disease. Prion 12:216\u2013225","journal-title":"Prion"},{"key":"2247_CR6","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1038\/s41593-024-01663-x","volume":"27","author":"Y Liu","year":"2024","unstructured":"Liu Y, Guo J, Matoga M, Korotkova M, Jakobsson P-J, Aguzzi A (2024) NG2 glia protect against prion neurotoxicity by inhibiting microglia-to-neuron prostaglandin E2 signaling. Nat Neurosci 27:1534\u20131544","journal-title":"Nat Neurosci"},{"key":"2247_CR7","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.3390\/v13091796","volume":"13","author":"E Gelpi","year":"2021","unstructured":"Gelpi E, Klotz S, Vidal-Robau N, Ricken G, Regelsberger G, Str\u00f6bel T et al (2021) Histotype-dependent oligodendroglial PrP pathology in sporadic CJD: a frequent feature of the M2C \u201cstrain.\u201d Viruses 13:1796","journal-title":"Viruses"},{"key":"2247_CR8","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1007\/s12035-015-9205-3","volume":"53","author":"B Ettle","year":"2016","unstructured":"Ettle B, Schlachetzki JCM, Winkler J (2016) Oligodendroglia and myelin in neurodegenerative diseases: more than just bystanders? Mol Neurobiol 53:3046\u20133062","journal-title":"Mol Neurobiol"},{"key":"2247_CR9","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00401-012-1002-8","volume":"124","author":"P Parchi","year":"2012","unstructured":"Parchi P, de Boni L, Saverioni D, Cohen ML, Ferrer I, Gambetti P et al (2012) Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA. Acta Neuropathol 124:517\u2013529","journal-title":"Acta Neuropathol"},{"key":"2247_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CRJ, Kawas CH et al (2011) The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7:263\u2013269","journal-title":"Alzheimers Dement"},{"key":"2247_CR11","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CRJ Jack","year":"2018","unstructured":"Jack CRJ, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB et al (2018) NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement 14:535\u2013562","journal-title":"Alzheimers Dement"},{"issue":"8","key":"2247_CR12","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr","year":"2024","unstructured":"Jack CR Jr, Andrews JS, Beach TG, Buracchio T, Dunn B, Graf A, Hansson O, Ho C, Jagust W, McDade E, Molinuevo JL, Okonkwo OC, Pani L, Rafii MS, Scheltens P, Siemers E, Snyder HM, Sperling R, Teunissen CE, Carrillo MC (2024) Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup. Alzheimers Dement 20(8):5143\u20135169. https:\/\/doi.org\/10.1002\/alz.13859","journal-title":"Alzheimers Dement"},{"key":"2247_CR13","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181c47cc2","volume":"73","author":"CE Teunissen","year":"2009","unstructured":"Teunissen CE, Petzold A, Bennett JL, Berven FS, Brundin L, Comabella M et al (2009) A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology 73:1914\u20131922","journal-title":"Neurology"},{"key":"2247_CR14","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1007\/s00415-022-11549-2","volume":"270","author":"P Hermann","year":"2023","unstructured":"Hermann P, Schmitz M, Cramm M, Goebel S, Bunck T, Sch\u00fctte-Schmidt J et al (2023) Application of real-time quaking-induced conversion in Creutzfeldt\u2013Jakob disease surveillance. J Neurol 270:2149\u20132161","journal-title":"J Neurol"},{"key":"2247_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00401-010-0691-0","volume":"121","author":"L Reiniger","year":"2011","unstructured":"Reiniger L, Lukic A, Linehan J, Rudge P, Collinge J, Mead S et al (2011) Tau, prions and A\u03b2: the triad of neurodegeneration. Acta Neuropathol 121:5\u201320","journal-title":"Acta Neuropathol"},{"key":"2247_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC et al (2012) National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimers Dement 8:1\u201313","journal-title":"Alzheimers Dement"},{"key":"2247_CR17","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T et al (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676\u2013682","journal-title":"Nat Methods"},{"key":"2247_CR18","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1152\/physrev.00031.2018","volume":"99","author":"C Stadelmann","year":"2019","unstructured":"Stadelmann C, Timmler S, Barrantes-Freer A, Simons M (2019) Myelin in the central nervous system: structure, function, and pathology. Physiol Rev 99:1381\u20131431","journal-title":"Physiol Rev"},{"key":"2247_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00726-021-03111-7","volume":"54","author":"V Martinsen","year":"2022","unstructured":"Martinsen V, Kursula P (2022) Multiple sclerosis and myelin basic protein: insights into protein disorder and disease. Amino Acids Austria 54:99\u2013109","journal-title":"Amino Acids Austria"},{"key":"2247_CR20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00415-024-12747-w","volume":"272","author":"F Maass","year":"2024","unstructured":"Maass F, Canaslan S, van Riesen C, Hermann P, Schmitz M, Schulte C et al (2024) Myelin basic protein and TREM2 quantification in the CSF of patients with multiple system atrophy and other parkinsonian conditions. J Neurol 272:52","journal-title":"J Neurol"},{"key":"2247_CR21","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1152\/physrev.2001.81.2.871","volume":"81","author":"N Baumann","year":"2001","unstructured":"Baumann N, Pham-Dinh D (2001) Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81:871\u2013927","journal-title":"Physiol Rev"},{"key":"2247_CR22","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1073\/pnas.042678799","volume":"99","author":"M Bifulco","year":"2002","unstructured":"Bifulco M, Laezza C, Stingo S, Wolff J (2002) 2\u2019,3\u2019-Cyclic nucleotide 3\u2019-phosphodiesterase: a membrane-bound, microtubule-associated protein and membrane anchor for tubulin. Proc Natl Acad Sci USA 99:1807\u20131812","journal-title":"Proc Natl Acad Sci USA"},{"key":"2247_CR23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.brainres.2015.06.003","volume":"1638","author":"D Sakry","year":"2016","unstructured":"Sakry D, Trotter J (2016) The role of the NG2 proteoglycan in OPC and CNS network function. Brain Res 1638:161\u2013166","journal-title":"Brain Res"},{"key":"2247_CR24","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1002\/glia.24342","volume":"71","author":"T Dean","year":"2023","unstructured":"Dean T, Ghaemmaghami J, Corso J, Gallo V (2023) The cortical NG2-glia response to traumatic brain injury. Glia 71:1164\u20131175","journal-title":"Glia"},{"key":"2247_CR25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13195-019-0562-4","volume":"12","author":"S Abu-Rumeileh","year":"2019","unstructured":"Abu-Rumeileh S, Steinacker P, Polischi B, Mammana A, Bartoletti-Stella A, Oeckl P et al (2019) CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia. Alzheimers Res Ther 12:2","journal-title":"Alzheimers Res Ther"},{"key":"2247_CR26","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1002\/acn3.51873","volume":"10","author":"S Abu-Rumeileh","year":"2023","unstructured":"Abu-Rumeileh S, Halbgebauer S, Bentivenga GM, Barba L, Baiardi S, Mastrangelo A et al (2023) High diagnostic performance of plasma and cerebrospinal fluid beta-synuclein for sporadic Creutzfeldt\u2013Jakob disease. Ann Clin Transl Neurol 10:1904\u20131909","journal-title":"Ann Clin Transl Neurol"},{"key":"2247_CR27","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13195-023-01300-y","volume":"15","author":"GM Bentivenga","year":"2023","unstructured":"Bentivenga GM, Baiardi S, Mastrangelo A, Zenesini C, Mammana A, Polischi B et al (2023) Diagnostic and prognostic value of cerebrospinal fluid SNAP-25 and neurogranin in Creutzfeldt-Jakob disease in a clinical setting cohort of rapidly progressive dementias. Alzheimers Res Ther 15:150","journal-title":"Alzheimers Res Ther"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-026-02247-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02247-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02247-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:01:02Z","timestamp":1781632862000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40478-026-02247-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2247"],"URL":"https:\/\/doi.org\/10.1186\/s40478-026-02247-5","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the Ethics Committee of the University Medical Center G\u00f6ttingen (Nr. 13\/11\/12, Nr. 37\/11\/21, Nr. 9\/6\/08, Nr. 11\/11\/93, Nr. 39\/2\/19). Written consent was obtained from all patients or caregivers. The study is in accordance with the Code of Ethics of the World Medical Association (Declaration of Helsinki).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}